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individuals samples. This band is likely to correspond to a candi-Effect of plasma fractions from patients with focal and segmen-
date albuminuric factor recently reported by another grouptal glomerulosclerosis on rat proteinuria.
[1], and was identified by microsequencing as a1 acid glycopro-Background. Patients suffering from focal and segmental
tein or orosomucoid. Consequently, purified orosomucoid fromglomerulosclerosis (FSGS) and in whom this disease recurs after
the plasma of FSGS, non-FSGS NS patients, or healthy individ-transplantation are likely to have an active form of the disease
uals was injected intra-arterially into rats. No differences wereand to have a factor(s) (such as, albuminuric factor) present
found between the proteinuria induced in each group.in their blood that alters glomerular permeability for albumin.
Conclusions. These data strongly suggest that in vivo injec-Methods. We used a sequential 50 and 70% ammonium sul-
tion of material into the rat is not a reliable model for testingfate (AS) precipitation of plasma from patients with relapsing
plasma fraction activity and that the 43 kD orosomucoid is notFSGS and non-FSGS nephrotic syndrome (NS), in addition to
plasma from healthy individuals, to obtain both an immunoglob- likely to be the albuminuric factor.
ulin (Ig)-rich fraction (50% AS precipitate) and a non-Ig fraction
(70% AS supernatant). These fractions were injected intra-
arterially or intravenously/intraperitoneally into Sprague-Daw-
Idiopathic focal and segmental glomerulosclerosisley rats, and proteinuria (g protein/mmol creatinine) was mea-
(FSGS) often immediately relapses after kidney trans-sured for 24 hours. Ig fractions eluted from immunoadsorption
onto protein A were also tested. A biochemical character- plantation, suggesting the presence of a circulating factor
ization was then carried out on the 70% AS supernatants by [albuminuric factor (AF)] that is capable of rapidly alter-
ultrafiltration on 30 and 50 kD cut-off membranes and by ing the glomerular permselectivity for albumin and ofsodium dodecyl sulfate-polyacrylamide gel electrophoresis
secondarily reproducing the initial histologic lesion on(SDS-PAGE). Differentially stained bands were sequenced.
the graft [reviewed in 2]. We have shown that removingResults. The 70% AS supernatants from FSGS patients in-
duced proteinuria when injected intra-arterially into normal immunoglobulin (Ig) from relapsing patients’ blood by
rats. This effect was significantly different (P , 0.05) from that immunoadsorption onto protein A columns [3] or by im-
observed when similar fractions were prepared from the plasma munoaffinity adsorption [4] strongly decreases protein-of patients suffering from non-FSGS NS, but was not different
uria (albeit transiently), thus demonstrating a link be-from that observed with fractions from healthy individuals and
tween AF and Ig. Despite the fact that plasma fromeven with an injection of saline solution. Injections of other
plasma fractions did not induce a significant proteinuria in the relapsing patients contains a factor that decreases in vitro
FSGS group versus the non-FSGS NS group. SDS-PAGE of glomerular permselectivity for albumin when tested on
70% AS supernatants revealed a protein of 23 kD that was isolated rat glomeruli [5–8], no definitive evidence hasmore concentrated in AS supernatants from FSGS plasma than
been obtained to suggest that it could be a marker ofthe other plasma samples and that was identified by micro-
disease activity and could predict an FSGS relapse aftersequencing as apolipoprotein A1. After sequential ultrafiltration
of 70% AS supernatants on 30 and 50 kD cut-off membranes, transplantation [6]. Indeed, only the capacity to trigger
a second band of 43 kD was found at a much higher concentra- proteinuria after the injection of an in vitro biologically
tion in the FSGS samples than in non-FSGS NS and healthy active fraction into animals would establish an unequivo-
cal relationship of such an activity with the disease etiol-
ogy. Several groups, including ours, have reported thatKey words: nephrotic syndrome, orosomucoid, albuminuric factor, glo-
merular permeability, proteinuria, post-transplant relapse. plasma (or plasma fractions or protein A column eluates)
from FSGS patients can induce a transient rise in protein-Received for publication December 23, 1999
uria after intravenous (IV), intraperitoneal (IP), or directand in revised form June 6, 2000
Accepted for publication June 9, 2000 infusion/perfusion into the rat kidney vasculature (ab-
stract; Shaloub et al, Kidney Int 19:191, 1981) [3, 9–12].Ó 2000 by the International Society of Nephrology
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Two recent studies have revisited the effect of injec- from the FSGS patients. Table 1 shows the main clinical
characteristics of FSGS and control NS patients. FSGStion of fractions containing a putative AF into rats. First,
relapse was defined as the appearance of selective pro-hemopexin (100 kF) [13] was shown to have an increased
teinuria within the weeks following transplantation andturnover in the serum of patients with idiopathic ne-
was also diagnosed from renal biopsies of both the pa-phrotic syndrome (INS) [14]. Further work is necessary
tient’s own kidney (initial disease) and the graft. Plasmato demonstrate its role in FSGS/INS. Second, it has been
from healthy individuals was obtained from the localsuggested that 70% ammonium sulfate (AS) superna-
blood bank. All plasma samples were handled undertants of FSGS sera can specifically induce proteinuria
sterile conditions and stored at 2208C until used.when injected intravenously into rats [1]. Furthermore,
Sharma et al identified a 30 to 50 kD protein in this Preparation of 70% ammonium sulfate supernatants
fraction. The absence of this protein in normal sera made and 50% precipitates
it a candidate for the albuminuric factor.
A two-step method (50 and 70%) was used to sequen-In this study, we have concentrated on the effects of
tially remove Ig and albumin from plasma. Plasma wasboth Ig and non-Ig fractions from plasma from relapsing
thawed, and the quantity of AS (Merck, Nogent s/Marne,FSGS patients. We report that a fraction from relapsing
France) necessary to obtain 50% saturation was added
FSGS patient plasma, containing only a low level of Ig, slowly. The mixture was placed at 48C overnight under
triggered proteinuria in the rat when injected intra-arteri- agitation. The mixture was then centrifuged at 3000 g for
ally. However, whereas this activity was statistically sig- 30 minutes, and the supernatant was removed. The pre-
nificant when compared with preparations obtained from cipitate was recovered, diluted, with distilled water until
plasma of non-FSGS nephrotic syndrome (NS), rats re- complete dissolution and dialyzed (molecular weight cut-
ceiving the same fraction from normal plasma or even the off 5 3500) against phosphate-buffered saline (PBS; 3
same volume of a saline solution also presented an in- changes) for two days. AS was added to the 50% super-
creased proteinuria. The sequencing of the purified 43 kD natant to reach 70% saturation and was agitated at 48C
band candidate for AF in this fraction revealed orosomu- overnight. The precipitate was removed by centrifuga-
coid. However, despite the fact that this molecule was tion at 3000 3 g for 30 minutes. The supernatant was
shown to be involved in the regulation of glomerular dialyzed (Spectra/por dialysis tubing, molecular weight
filtration ex vivo [15, 16], we were unable to demonstrate cut-off 5 3500; Polylabo, Strasbourg, France) against
its capacity to induce proteinuria when injected into the distilled water (5 changes) and PBS (4 changes) for three
rat renal artery. days. All supernatants were concentrated tenfold with
respect to the initial plasma volume using polyethylene
glycol (PEG) (molecular weight 35,000 D; Merck) in or-
METHODS der to preserve the initial proportion of the putative
Animals “AF” in the solution. The mean final protein concentra-
tion in supernatants was 4.9 6 4.5 g/L, except for oneStudies were performed on healthy male Sprague-
sample (T), in which the protein content was 25.4 g/L.Dawley rats (250 to 275 g; Janvier, Le Genest Saint Isle,
The protein content of each 50% precipitate was mea-France), which were fed standard laboratory food and
sured, and solutions were diluted to obtain a proteinwater for one week prior to injection. Animal experimen-
concentration in the range of the 70% AS supernatanttation was conducted in accordance with the National
concentration. Thus, the mean protein concentration inInstitutes of Health Guide for the Care and Use of Labo-
precipitates was 8.62 6 0.65 g/L.ratory Animals.
UltrafiltrationPatient plasma
Seventy percent of the AS supernatants were filtered
Plasma samples were obtained from plasmapheresis using an ultrafiltration cell (Amicon, Beverly, MA, US)
procedures on patients with FSGS who had presented and a 50 kD Omega membrane (Pall Corporation, St.
a relapse of their initial disease. Control plasma was Germain en Laye, France) at 1.0 bar, under agitation at
obtained from kidney recipients with NS of an origin 48C. The 50 kD ultrafiltrate was then filtered using a 30
other than FSGS, including one patient with nephroangi- kD membrane (Amicon) at 1.6 bar, under agitation at
osclerosis, one with diabetes, and another with IgA ne- 48C. The 30 kD retained fraction constituted the 30 to
phritis. The first two patients presented an allograft glo- 50 kD fraction of the 70% AS supernatant.
merulonephritis related to chronic rejection and the third
Preparation of protein A column eluates–anti-Galpresented a late relapse of IgA nephritis. All of these
antibody depletioncontrol non-FSGS patients were also under immunosup-
pression with cyclosporine A, and their mean proteinuria The protein A eluate from FSGS patient plasma was
obtained as described previously [3]. The eluate from NSand blood albumin levels were not significantly different
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Table 1. Clinical parameters for the initial kidney disease and the nature of graft functional alteration (initial disease relapse or allograft
glomerulonephritis) in FSGS and control patients
Immunosuppressive
Patient Age Sex Initial disease treatment Tx
G 46 F MCGN CS/CYP 1st Cad K
B 33 F FSGS CS/CsA 1st Cad K
D 20 F MCGN CS/CsA 1st Cad K
T 37 F FSGS CS/CYP 1st Cad K
V 26 M MCGN CS/CYP 2nd Cad K
L 60 M Nephroangiosclerosis No 1st Cad K
H 40 M Diabetes No 1st Cad K
LH 58 M IgA nephritis No 1st Cad K
(continued)
plasma was obtained by passage through a protein A reagents. In all of the AS supernatants, IgA and IgM
were undetectable.column: After centrifugation to remove lipids, the plasma
was passed through the column. Then the column was
Sequencing of electrophoretic bandswashed thoroughly with PBS and eluted with 200 mL of
Proteins were separated by SDS-PAGE in a 10% poly-0.2 mol/L glycine-HCl buffer, pH 2.5. The eluate was
acrylamide gel (1.5 mm thick). The gel was fixed twicerecovered, neutralized with 1 mol/L Na2HPO4, and dia-
for 30 minutes in 50% methanol-10% acetic acid, stainedlyzed (Spectra/por dialysis tubing, molecular weight cut-
overnight with 0.003% amido-black, and destained withoff 5 3500) against PBS (3 changes) for two days. The
water. The protein-containing gel bands were cut outcolumn was successively washed with 2 mol/L urea,
and submitted to protease digestion. The 68 and 43 kD1 mol/L lithium chloride, and 0.2 mol/L glycine-HCl,
bands were digested using endoprotease Lys C. The 23 kDpH 2.5. The column was stored in PBS 0.05%-NaN3. The
band was digested using trypsin. Peptides were separatedprotein concentration in the protein A eluate was 6 g/L
by high-performance liquid chromatography (HPLC) onfor the FSGS sample and 4 g/L for the NS sample.
a 2 mm 3 25 cm C18 reverse-phase column with a DEAESynthetic Gala1-3Gal disaccharide-polyacrylamide
precolumn. Elution was performed with a gradient ofconjugates covalently linked to Sepharose 6FF were used
acetonitrile/water 0.1% trifluoacetic acid (TFA). One orfor the removal of anti-Gal antibodies (Xenotran; Synte-
two of the best defined peptide peaks of each analysissome GmbH, Munich, Germany) by immunoadsorption.
were submitted to sequencing on a Procise sequencerEach protein A eluate was passed through the immuno-
(Applied Biosystem, Foster City, CA, USA). Digestion,adsorption column and dialyzed against PBS (3 changes)
HPLC, and sequencing were performed at the Proteinfor two days. The column was washed with PBS, eluted
Microsequencing Laboratory at the Pasteur Institutewith 1% NH4OH, and stored with PBS-NaN3. The total (Paris, France).
protein content, after depletion of anti-Gal Ab, was 4 g/L
for the FSGS and 3 g/L for the NS eluate. Orosomucoid preparation
Isolation was carried out by trichloroacetic acid (TCA)SDS-PAGE, Western blot, and protein assays
precipitation of all other proteins [18] to obtain an ap-
Proteins (0.6 mg) were analyzed by sodium dodecyl sul- proximate 95% purity. Briefly, cold plasma samples were
fate-polyacrylamide gel electrophoresis (SDS-PAGE), mixed (vol/vol) with a refrigerated 10% TCA solution
under reducing conditions, on an 12% polyacrylamide gel under agitation and left on ice overnight. The mixture
according to Laemmli [17]. Proteins were silver stained, was centrifuged at 10,000 3 g for 30 minutes at 48C. The
and the gel was stored in a 10% glycerol solution. Alter- supernatant was removed and lyophilized. It was dissolved
natively, proteins were transferred onto a nitrocellulose in PBS, and the pH was adjusted to 7.4 with 1N NaOH.
membrane, and Western blots were carried out using the Efficient purification was confirmed by SDS-PAGE analy-
ECL Western Blot kit (Amersham, Arlington Heights, sis. The final orosomucoid concentration was between
IL, USA) together with peroxidase-conjugated antibod- 0.55 and 0.89 g/L.
ies: anti-g (A2290 Sigma; 1/1000), anti-k (A7164 Sigma;
In vivo injections of plasma fractions into rats1/1000), anti-l (A5175 Sigma; 1/1000), and antiorosomu-
coid (A0011 Dako; 1/5000). Intra-arterial injections were performed first. Animals
Albumin and Ig (G, A, and M) content was assessed by were placed in metabolic cages for 24 hours before injec-
nephelemetry, using a BN II nephelemeter (Dade Beh- tion to determine the preinjection level of proteinuria.
Rats were anesthetized by a mixture of isofluoran/oxy-ring S.A, Paris La De´fense, France) with Behring assay
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Table 1. Continued
Onset of Graft Serum creatinine Proteinuria
Treatment proteinuria pathology Time of PE at PE lmol/L range g/day
CsA/MMF 14 d MCGN 9 mo 130 4 to 5
CsA/MMF 10 d MCGN 6 mo 129 3 to 4
CsA/AZA/CS 7 d MCGN 2 mo 400 15 to 20
CsA/MMF 7 d FSGS 3 yr 164 7 to 9
CsA/MMF/CS 8 d MCGN 1 mo 94 18 to 22
CsA/AZA 9 mo Allograft Gn 3 yr 371 6 to 7
CsA/AZA 4 yr Allograft Gn 8 yr 180 5 to 8
CsA/AZA/CS 3.5 yr IgA nephritis 3.5 yr 160 3 to 4
Abbreviations are: PE, plasmatic exchange; FSGS, focal and segmental glomerulosclerosis; MCGN, minimal change glomerulonephritis; CS, corticosteroids;
Cad K, cadaveric kidney; CsA, cyclosporine A; CYP, cyclophosphamide; AZA, azathioprine; MMF, mycophenolate mofetil; Tx, transplantation.
gen, and the right kidney was removed. The aorta was France). Proteins were stained with amido-black. The
scanning of nondenaturating electrophoresis by a densi-clamped above and below the left kidney artery, and the
plasma fractions (1 mL) were slowly (5 to 8 minutes) tometer (Hysys, Sebia, Issy Leo Noulineaux, France)
allowed an integration of the electrophoresis pattern,injected directly into the aorta under the junction with
which determined the percentage of albumin containedthe left renal artery (the total time of ischemia was about
within the urine samples.10 minutes). Rats were allowed to recover from anesthe-
sia and were transferred to metabolic cages. Urine sam-
Statistical analysisples were collected for 24 hours following the injection,
Results are expressed as mean 6 SD. The nonpara-and diuresis was measured.
metric Wilcoxon test was used to compare the effects ofThis procedure was chosen in order to increase the
the various plasma fractions on rat proteinuria beforeexposure of the recipient’s kidney to the putative albumin-
and 24 hours following the injection. P , 0.05 was ac-uric factor. As it could also have induced aspecific lesions
cepted as significant.caused by local ischemic damage, we separately collected
the urine produced within the six hours following injec-
tion and that produced during the following 18 hours
RESULTS(6 to 24 hours).
Protein content of different plasma fractionsFinally, for the same reasons, the effect of IV/IP injec-
tions of plasma fractions was also investigated. Animals Sodium dodecyl sulfate-polyacrylamide gel electro-
whose proteinuria level had previously been measured phoresis of 70% AS supernatants showed one major and
were anesthetized, and the plasma fractions (1 mL) were multiple minor protein bands (Fig. 1). The major band
injected into the penis dorsal vein. One milliliter of the (molecular weight of 68 kD) was confirmed to be albu-
same fraction was then injected intraperitoneally. The min (Table 2). The minor band of approximately 23 kD
same two (IV-IP) injections were repeated 48 and 72 hours was more concentrated in FSGS than in non-FSGS NS
later. Urine was collected in metabolic cages for 24 hours and normal plasma fractions. Upon sequencing, it was
after the first and the third injection. identified as apoliprotein A1 (Table 2). Other proteins
Each rat received one sample of individual fraction appeared to be equally distributed among the different
(from one patient), and this sample was injected into at supernatants. Heavy and light Ig chains appeared as mi-
least three rats (from 3 to 7 rats for one individual sample nor components, although they could be detected by
in one type of injection). Western blotting (data not shown). After PEG treat-
ment, the albumin concentration in the 70% AS superna-
Measurement of proteinuria and urine electrophoreses tants was below 2.5 g/L, except for the supernatant from
the single FSGS patient T, where it was 11.9 g/L. The IgRats were placed in metabolic cages with free access to
water but without food. The total protein concentration concentration (exclusively IgG) was always below 0.5 g/L.
After ultrafiltration on 50 and 30 kD membranes, the(g/L) of urine was measured by a colorimetric test using
an autoanalyzer Hitachi 717 (Boehringer, Mannheim, 30 to 50 kD fraction of the 70% AS supernatant from
an FSGS plasma sample contained three major proteins:Germany). Urinary creatinine was measured by the Jaffe
method and expressed in mmol/L. Proteinuria was ex- albumin, a 23 kD protein confirmed as apolipoprotein
AI, and a 43 kD protein, which was not detected in thepressed as the ratio (g/mmol) of total protein (g/L) to
urinary creatinine (mmol/L). non-FSGS NS plasma (Fig. 2). The 43 kD protein was iso-
lated by preparative gel electrophoresis and sequencedAgarose electrophoresis of urinary proteins was per-
formed using the Protur Hisi kit (Beckman, Gagny, (Table 2). It was identified as the a1 acid glycoprotein,
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Fig. 1. SDS-PAGE of 70% ammonium sulfate
(AS) supernatants of different plasma. Pro-
teins (0.6 mg) were analyzed in a 12% poly-
acrylamide gel under reducing conditions with
Laemmli buffers. Proteins were silver stained.
Lanes are: (1) healthy individuals, (2–4) focal
and segmental glomerulosclerosis (FSGS), (5
and 6) non-FSGS nephrotic syndrome (NS),
and (7) protein A column eluate of plasma
from a patient with hemochromatosis, en-
abling the position of albumin, heavy and light
Ig chains to be located (arrows).
Table 2. Sequence of peptides separated by HPLC after protease shown). Preparations from non-FSGS NS patients only
digestion of proteins isolated by SDS-PAGE
moderately influenced basal proteinuria values (0.167 6
Peptides Sequences Proteins 0.034 vs. 0.23 6 0.014 g/mmol, P 5 NS). However, an
1 AWAVARLSQRFPKAE Albumin injection of AS supernatants from healthy individuals
2 LLDNWSVTSTFSK Apo AI was also associated with a rise in protein excretion of
3 VKDLATVYVDVLK Apo AI
approximately the same magnitude as that seen after injec-4 TYMLAFDVNDEK Orosomucoid
tion of AS supernatants from FSGS patients (0.169 6In peptides 1 to 3, proteins were isolated from the 70% ammonium sulfate
(AS) supernatant of FSGS patient B. In peptide 4, protein was isolated from 0.022 vs. 0.29 6 0.059 g/mmol). Furthermore, a similar
the 30 to 50 kD fraction of FSGS patient B. volume of isotonic saline also had a significant effect of
roughly the same magnitude (0.171 6 0.025 vs. 0.279 6
0.059 g/mmol). Separate analysis of urine collected from
0 to 6 hours and from 6 to 24 hours postinjection [1]also known as orosomucoid. Orosomucoid was present
gave similar results (data not shown).in the fractions prepared from other FSGS patients; al-
Before the injection, albumin was found to accountthough not silver stained, it was also detected by Western
for 76 6 20% of the protein in rat urine. The percentageblot in preparations from both normal individuals and
of albumin present in the urine did not increase signifi-non-FSGS NS patients (Fig. 3).
cantly during the 24 hours following injection of ASThree bands were detected following SDS-PAGE of
supernatants from FSGS (79.7 6 8.5%), non-FSGS NS50% AS precipitates; these were identified as albumin,
patients (78.5 6 9.6%), healthy individuals (83.8 6 8%),and Ig light and heavy chains (data not shown). The
or saline (84 6 0.7%).electrophoresis of different protein A column eluates
No significant difference was found between the pre-revealed the two major bands corresponding to heavy
and the post-IV-IP injection proteinuria level in the threeand light Ig chains in addition to albumin and other
groups (Fig. 4B): the non-FSGS NS group (0.123 6 0.03minor components (Fig. 1, lane 7).
vs. 0.14 6 0.032 g/mmol), the FSGS group (0.136 6 0.03
Effect of injection of 70% AS supernatants into rats vs. 0.15 6 0.026 g/mmol), and the healthy group (0.139 6
0.05 vs. 0.17 6 0.068 g/mmol).The effect of the intra-arterial injections of 70% AS
supernatants and of an isotonic saline solution on pro-
Effect of injection of 50% AS precipitates into ratsteinuria was compared first. Figure 4A shows a border-
After the intra-arterial injection of 50% AS precipitatesline significant increase in urinary protein excretion in
(2.2 6 0.65 g/L albumin concentration), a nonspecificthe FSGS group 24 hours following injection, as com-
increase in proteinuria occurred in the three groups: non-pared with preinjection values (0.178 6 0.019 vs. 0.29 6
FSGS NS (0.111 6 0.032 vs. 0.315 6 0.122 g/mmol), FSGS0.075 g/mmol, P , 0.05). Proteinuria reverted to the
baseline value 48 hours following injection (data not (0.112 6 0.021 vs. 0.278 6 0.086 g/mmol; Fig. 4C), and
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Fig. 3. Western blot with anti-orosomucoid performed on 70% AS su-
pernatants of different plasma. Lanes are: (1) healthy individuals, (2–4)
FSGS, (5 and 6) non-FSGS NS, and (7) orosomucoid isolated from
plasma by TCA precipitation.
relationship (r 5 0.45) was detected (data not shown), thus
suggesting that the difference observed was not caused
Fig. 2. SDS-PAGE of the 30 to 50 kD fraction of 70% ammonium by protein overload. A similar conclusion was obtained
sulfate supernatants. Lane 1, FSGS plasma; lane 2, non-FSGS nephrotic when the total amount of injected protein was plotted
syndrome plasma.
against proteinuria.
Effect of intra-arterial injection of patient-derived
orosomucoid into ratsthe healthy group (0.112 6 0.021 vs. 0.311 6 0.15 g/mmol).
Since orosomucoid from FSGS patients could haveSimilarly, IV-IP injections of 50% AS precipitates from
undergone discrete modifications post-transplant thatthe various groups (non-FSGS NS, FSGS, and healthy
could have altered its capacity to interfere with glomeru-individuals) had no effect on proteinuria (Fig. 4D).
lar permselectivity, orosomucoid preparations from both
FSGS and non-FSGS NS plasma were injected into theEffect of injection of protein A column eluates
rat renal artery.The intra-arterial injection of protein A column eluates
As it was reported that significant differences in pro-that were not depleted of anti-Gal Ab (Fig. 5A) resulted
teinuria following AS supernatant injection were ob-in a roughly similar proteinuria in the two groups (0.125 6
served in urine collected between 6- and 24-hours postin-0.022 vs. 0.187 6 0.079 g/mmol for the non–FSGS NS
jection [1], we analyzed the proteinuria during the firsteluates and 0.125 6 0.022 vs. 0.216 6 0.82 g/mmol for
6 hours and during the following 18 hours. Proteinuriathe FSGS eluates, P 5 NS). Human serum contains high
during the first six hours was increased to the same extentlevels (estimated to be 1% of total Ig) of xenoantibodies
in each group (data not shown). Figure 6 shows that theredirected against most mammalian endothelial cells [19].
was no difference in 24-hour urinary protein excretionAs the injected fractions contain xenoantibodies, which
between rats injected intra-arterially with the orosomu-are able to bind strongly and activate the renal endothe-
coid fraction prepared from normal plasma, plasma fromlium and possibly result in nonspecific proteinuria, thus
FSGS patients, and plasma from non-FSGS NS patientsmasking the effect of the putative albuminuric factor, we
(P 5 0.018, P 5 0.028, and P 5 0.018, respectively).decided to remove the anti-Gal antibodies by immuno-
adsorption. Depletion of anti-Gal Ab (Fig. 5 C, D) did not
DISCUSSIONreveal an effect of FSGS versus non-FSGS NS fractions.
The immediate recurrence of idiopathic NS after renal
Correlation between albumin content in AS transplantation strongly suggests the involvement of cir-
supernatants and proteinuria culating factor(s) in the pathogenesis of this disease.
Since our aim was to determine whether plasma from Thus, characterization of this factor would represent a
relapsing patients contained an uncharacterized AF, we major breakthrough in understanding its pathology. Some
injected a similar volume of the material from FSGS, authors have suspected a T-cell product to be involved
non-FSGS NS, and normal plasma into the rat. However, [23–25]. Others have reported vascular permeability ac-
as the injected protein content varied, particularly with tivity [9, 26, 27] or implied that cationic agents allowed
respect to albumin, and since in some conditions protein- a leakage of albumin through the glomerular urinary
uria has been related to protein overload [20–22], we space [28–30]. However, the nature of the factor(s) re-
checked whether the quantity of albumin injected and sponsible for this disease remains elusive. Recently, we
showed the dramatic effect of ex vivo protein A [3] andthe level of proteinuria were correlated. No significant
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Fig. 4. Proteinuria after injection of plasma
fractions into the rat vasculature. Urine was
collected for 24 hours. Data are expressed as
mean protein (g/L)/creatinine (mmol/L) 6 SD
(error bars). The Wilcoxon statistical test was
used to compare preinjection data and postin-
jection data for each group. A significant P
was indicated by an asterisk. (A) Effect of
intra-arterial injection of 70% AS superna-
tants. Four groups were tested: the non-FSGS
NS (3 patient fractions), the FSGS (5 patient
fractions), the healthy individuals group (19
rats, 4 patient fractions, not shown), and the
saline group (10 rats). (B) Effect of intrave-
nous and IP injection of 70% AS supernatants.
Three groups were tested: the non-FSGS NS
(3 patient fractions), the FSGS (5 patient frac-
tions), and the healthy individuals group (12
rats, 3 patient fractions, not shown). (C ) Effect
of intra-arterial injection of 50% AS precipi-
tates. Three groups were tested: the non-FSGS
NS (2 patient fractions), the FSGS (3 patient
fractions), and the healthy individuals group
(7 rats, 2 patient fractions, not shown). (D)
Effect of IV-IP injection of 50% AS precipi-
tates. Three groups were tested: the non-
FSGS NS (2 patient fractions), the FSGS (3
patient fractions), and the healthy individuals
group (12 rats, 2 patient fractions, not shown).
N 5 total number of rats in each group. Sym-
bols in A and C are: ( ) pre-injection; ( )
post-injection. Symbols in B and D are: ( )
pre-injection; ( ) post-injection; (j) third in-
jection.
anti-human Ig immunoaffinity columns [4] on protein- by the lack of correlation between the amount of human
albumin injected into rats and the induction of protein-uria in relapsing patients, suggesting the involvement of
immunoglobulin in the recurrence of FSGS following uria. The FSGS-derived sample was the only fraction in
the 70% AS supernatants to induce a significant increasetransplantation. Although in our experience, membra-
nous glomerulonephritis and primary FSGS patients in urinary protein excretion at 24 hours as compared
with preinjection values. Surprisingly, an injection of ASwere not always sensitive to protein A adsorption [3, 31],
this treatment may decrease albuminuria in other forms supernatants from healthy individuals as well as the in-
jection of saline also resulted in a large increase in pro-of NS [32]. Since fractions from protein A column eluates
with a molecular weight below 100 kD that were from teinuria as compared with the 24-hour preinjection val-
ues. This increase in proteinuria following the injectiontwo of the four patients originally tested have induced
albuminuria in rats [3], we hypothesized that the factor of a similar volume of preparations from healthy individu-
als or of saline suggests that this effect was due to ancould be either an immunoglobulin fragment or an im-
munoglobulin binding protein. We have now reinvesti- increase in the plasma volume and in the glomerular
filtration rate following injection. However, the minorgated the in vivo effect of Ig-depleted fractions obtained
from plasmapheresis fluids when injected into rats. Thus, increase in proteinuria in the non-FSGS NS group sug-
gests that more complex interactions can operate whenusing a simple technique of sequential protein precipita-
tion with AS, similar to that recently utilized by Sharma NS samples are used. Therefore, this highlights the im-
portance of comparing the effect of FSGS-derived super-et al [1], we removed almost all immunoglobulin and the
majority of albumin from plasma. Finally, the quantity natants with appropriate controls such as non-FSGS ne-
phrotic sera and of mimicking as closely as possible theof injected proteins was lower than that able to give a
nonspecific protein-loading effect [20–22], as also shown volume of material injected. Furthermore, the absence
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Fig. 5. Proteinuria after injection of plasma
fractions into the rat vasculature. Urine was
collected for 24 hours. Data are expressed as
mean protein (g/L)/creatinine (mmol/L) 6 SD
(error bars). The Wilcoxon statistical test was
used to compare pre-injection data and post-
injection data for each group. A significant
P was indicated by an asterisk. One patient
fraction was used in each group. (A) Effect
of intra-arterial injection of protein A column
eluates. Two groups were tested: the non-
FSGS NS and the FSGS group. (B) Effect of
IV-IP injection of protein A column eluates.
Two groups were tested: the non-FSGS NS
and the FSGS group. (C ) Effect of intra-arte-
rial injection of protein A column eluates de-
pleted of anti-Gal antibodies. Two groups
were tested: the non-FSGS NS and the FSGS
group. (D) Effect of IV-IP injection of protein
A column eluates depleted of anti-Gal anti-
bodies. Two groups were tested: the non-
FSGS NS and the FSGS group. N 5 total
number of rats in each group. Symbols in A
and C are: ( ) pre-injection; ( ) post-injec-
tion. Symbols in B and D are: ( ) pre-injec-
tion; ( ) post-injection; (j) third injection.
of any increase in the albumin content of urine suggests from plasma from four relapsing FSGS patients signifi-
cantly induced proteinuria in rats when compared withthe occurrence of a nonspecific effect. Finally, because
direct intra-arterial injection of the various fractions AS preparations obtained from normal individuals [1].
However, the authors did not show the effect of prepara-tested could have induced nonspecific ischemic lesions,
which may have hidden an effect of the material injected tions from patients with non-FSGS NS, thus making any
comparison between different experimental series diffi-and that anti-Gal antibodies were not involved, all of the
experiments were repeated with IV-IP injection, without cult. Interestingly, when urinary protein levels for the
first six hours following injection were not taken into ac-any further effect. These series of experiments, which
have been performed on a much larger scale both in the count (as in their report [1]), the general proteinuria pat-
tern between groups in our experiments was not modified.number of sera tested individually (non-FSGS NS 5 3
different sera, FSGS 5 5 different sera) and in the num- Several factors could explain the transient or lack of
effect on proteinuria following the transfer of FSGS bio-ber of rats injected (7 to 20 per group for intra-arterial
injections and 12 per group for IV-IP injections, a total logical materials: (1) The factor may be delivered at a
much lower concentration than in the pathological stateof 237 rats were injected), do not confirm our previous
data obtained for two patients (from the first 4 who (even when injected directly into the kidney vasculature)
and could also be rapidly eliminated with no continuousunderwent the initial protein A procedure reported [3]).
A recent report stated that similar AS preparations synthesis occurring. (2) The factor could be neutralized
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its anionic properties, suggests that Apo AI has no role
in FSGS. Furthermore, a 43 kD band only detected in
FSGS-derived preparations was identified as orosomu-
coid. A band with similar characteristics (but which was
not sequenced) was recently proposed as a putative albu-
minuric factor by Sharma et al [1]. Interestingly, oroso-
mucoid was shown to restore glomerular permselectivity
for albumin during ex vivo perfusion of isolated rat kid-
neys [16]. Since discrete alterations in the biochemical
properties of this highly anionic molecule in FSGS pa-
tients could form a basis for its potential role in FSGS,
we purified orosomucoid from the plasma of FSGS, non-
FSGS NS, and healthy individuals, and injected it into
the rat kidney vasculature. No evidence for a specific
induction of proteinuria was found.
In summary, we have shown that a single intra-arterial
injection of low-protein-containing plasma fractions from
patients with an FSGS recurrence following transplanta-
tion induces a mild and transient proteinuria. However,
although preparations from non-FSGS NS could not re-
Fig. 6. Proteinuria after injection of orosomucoid purified from plasma. produce this effect, normal sera or even saline resulted
Urine was collected for 24 hours. Data are expressed as protein (g/L)/ in a signal of a similar magnitude. Furthermore, we show
creatinine (mmol/L) 6 SD. Three groups of seven rats were tested with
that the 43 kD fraction proposed as a putative AF [1] isorosomucoid derived from FSGS (3 patient fractions), non-FSGS NS
(one patient fraction), and healthy individuals plasma (one patient orosomucoid, and that injection of this material derived
fraction). P was significant in the three groups. Symbols are: ( ) pre- from FSGS plasma into the rat kidney vasculature in-
injection; ( ) post-injection.
duced the same level of proteinuria as compared with
the 43 kD fraction prepared from the control plasma.
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